Emerging Infectious Disease ISSN: 1080-6059

Human Metapneumovirus RNA in Encephalitis Patient

Oliver Schildgen*¹

, Thomas Glatzel*¹, Tilman Geikowski*, Bärbel Scheibner*, Arne Simon*, Lutz Bindl*, Mark Born*, Sergei Viazov†, Anja Wilkesmann*, Gisela Knöpfle*, Michael Roggendorf†, and Bertfried Matz*

Author affiliations: *University of Bonn, Bonn, Germany; †University Hospital Essen, Essen, Germany; 1These authors contributed equally to this study.

Main Article

Figure 2

Alignment of 302 nucleotide human metapneumovirus (HMPV) sequences amplified from brain and lung tissues of the patient and from the supernatant of infected Vero cell culture. Sequence of the HMPV strain NLD00-1 was used as a prototype sequence. Conditions of the reverse transcription–polymerase chain reaction were described elsewhere (5).

Figure 2. . Alignment of 302 nucleotide human metapneumovirus (HMPV) sequences amplified from brain and lung tissues of the patient and from the supernatant of infected Vero cell culture. Sequence of the HMPV strain NLD00-1 was used as a prototype sequence. Conditions of the reverse transcription–polymerase chain reaction were described elsewhere (5).

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.